Anthony Barone, MD
Otolaryngology · Cranston, RINPI 1316980121
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Zimmer Biomet at 31.2% of the total. Reporting peaked in 2021 at $168 and has fallen 79.2% since, to $35 in 2024. That places this record below the midpoint for otolaryngology clinicians in RI, where the typical reported total is $1,573.
Across 16 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$114
- Optinose US, Inc.$71
- Kaleo, Inc.$51
- Hikma Pharmaceuticals USA$48
- Regeneron Healthcare Solutions, Inc.$33
- Alk-abello, Inc$17
- plus $31 from 2 others
What the payments were for
- Food & beverage$364100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 1 | $114 |
| Optinose US, Inc. | 4 | $71 |
| Kaleo, Inc. | 3 | $51 |
| Hikma Pharmaceuticals USA | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Alk-abello, Inc | 1 | $17 |
| Sanofi | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tapered Screw$114
How this compares
$364 in reported general payments places this provider in the 30th percentile of 23 otolaryngology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 56 | $1,528 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 22 | $1,436 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $934 |
| Ipratropium Bromide | 23 | $851 |
| Ofloxacin | 30 | $639 |
| Mometasone Furoate | 53 | $569 |
| Montelukast Sodium | 47 | $309 |
| Levocetirizine Dihydrochloride | 15 | $303 |
| Fluticasone Propionate | 14 | $283 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $239 |
| Methylprednisolone | 28 | $198 |
| Ciprofloxacin Hcl | 14 | $124 |
| Prednisone | 48 | $93 |
| Azithromycin | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Cranston
- Frederick GodleyProvidence$96K
- Mark AndreozziWarwick$15K
- Alejandro VazquezWarwick$10K
- Amit PatelWarwick$7K
- David CameronWesterly$7K
- Jeffrey FeldmanWesterly$4K
- John TarroProvidence$4K
- Barbara GuilletteWarwick$4K
- Eugene StecWesterly$4K
- Prabhakar TipirneniWakefield$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.